FindTrial
Sign In

Detection of circulating tumor cells and clinical significance of androgen receptor expression in peripheral blood of patients with prostate cancer

Detection of circulating tumor cells and clinical significance of androgen receptor expression in peripheral blood of patients with advanced prostate cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016142
Enrollment
Unknown
Registered
2018-05-14
Start date
2018-05-14
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostatic cancer

Interventions

Case series:Medication

Sponsors

Shandong Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Metastatic prostate cancer

Exclusion criteria

Exclusion criteria: Early prostate cancer

Design outcomes

Primary

MeasureTime frame
circulating tumor cell;—

Countries

China

Contacts

Public ContactWang Huansheng

Shandong Cancer Hospital

whslc2002@163.com+86 15553119035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026